Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 46 results
Filters: Author is Collier, Ann C  [Clear All Filters]
Found 46 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

S

Sax PE, Tierney C, Collier AC, et al. "Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy." N. Engl. J. Med.. 2009;361(23):2230-40.
Sax PE, Tierney C, Collier AC, et al. "Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results." J. Infect. Dis.. 2011;204(8):1191-201.
Schacker TW, Bosch RJ, Bennett K, et al. "Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV." J. Acquir. Immune Defic. Syndr.. 2010;54(1):59-62.
Smith KY, Tierney C, Mollan K, et al. "Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine." Clin. Infect. Dis.. 2014;58(4):555-63.
Smurzynski M, Collier AC, Koletar SL, et al. "AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics." HIV Clin Trials. 2008;9(4):269-82.
Smurzynski M, Wu K, Benson CA, Bosch RJ, Collier AC, Koletar SL. "Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study." J. Acquir. Immune Defic. Syndr.. 2010;55(1):117-27.
Smurzynski M, Wu K, Schouten JT, et al. "Factors associated with remaining on initial randomized efavirenz-containing regimens." AIDS. 2013;27(12):1887-97.
Smurzynski M, Wu K, Letendre S, et al. "Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort." AIDS. 2011;25(3):357-65.
Stockdale AJ, Saunders MJ, Boyd MA, et al. "Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis." Clin. Infect. Dis.. 2018;66(12):1846-1857.

Pages